Local Institution - 0078

Zurich 8091

1 studies enrolling now · 2 studies all time

What they study most

Stage IV or Recurrent Non-Small Cell Lung Cancer, Systemic Sclerosis

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis — Starting soon
• An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) — Completed